CHE - NYSE
Chemed Corporation
$426.86
-0.030%Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
At a Glance
Live Snapshotche
Total Non-Current Liabilities
Last Annual Value
373.48M
3-Year CAGR
3%
5-Year CAGR
10%
10-Year CAGR
8%
Chemed Corporation Competitors Analysis of Total Non-Current Liabilities
| Company | Total Non-Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Chemed Corporation NYSE:CHE | 373.48M | 14.6% | -2.2% | 7.3% | |
 Nuvalent, Inc. NASDAQ:NUVL | 73.19M | N/A | N/A | N/A | |
 Option Care Health, Inc. NASDAQ:OPCH | 1.30B | 0.3% | 0.2% | 9.8% | |
 Teleflex Incorporated NYSE:TFX | 3.06B | 7.2% | 4.7% | 8.7% | |
 Henry Schein, Inc. NASDAQ:HSIC | 3.19B | 5.3% | 16.3% | 12.0% | |
 AptarGroup, Inc. NYSE:ATR | 1.37B | 16.0% | 3.2% | 4.4% | |
 DaVita Inc. NYSE:DVA | 13.18B | 4.6% | 1.3% | 2.6% | |
 Metsera, Inc. NASDAQ:MTSR | 96.33M | 24.3% | N/A | N/A | |
2.68B | -10.0% | -6.9% | N/A | ||
 Bruker Corporation NASDAQ:BRKR | 2.45B | 14.5% | 8.6% | 15.2% |
Chemed Corporation Fair Value Envelope
Related Guides
Continue your CHE research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.